# Q3B(R) Impurities in New Drug Products (Revision 3) - FDA Guidance Document

Source: https://www.keypedia.com/guidances/guidance-document/q3br-impurities-in-new-drug-products-revision-3/a2e10295-fed5-4751-9af6-54da8d5c29c3

> FDA guidance document: Q3B(R) Impurities in New Drug Products (Revision 3). Issue date: August 04, 2006. Get complete insights and analysis.

---

## Details

- Title: Q3B(R) Impurities in New Drug Products (Revision 3)
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2006-08-04
- Last Changed: 2021-09-29
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-1996-D-0048 (Revision 1)  ">FDA-1996-D-0048 (Revision 1)  </a>

## Related Documents

- [M4: The CTD -- Efficacy Questions and Answers](https://www.keypedia.com/guidances/guidance-document/m4-the-ctd-efficacy-questions-and-answers/7d54ebee-7959-4925-b48e-48350bf0759b)
- [Q1A(R2) Stability Testing of New Drug Substances and Products](https://www.keypedia.com/guidances/guidance-document/q1ar2-stability-testing-of-new-drug-substances-and-products/91828b9f-0f69-4b32-8309-b0a7cc4ba7f1)
- [M4:  The CTD -- General Questions and Answers](https://www.keypedia.com/guidances/guidance-document/m4-the-ctd-general-questions-and-answers/84e702f8-2534-4e9e-a14b-d644b13bd0d2)